drugset / Trial / NCT03018418

Proton Therapy in Reducing Toxicity in Anal Cancer

NCT03018418

Phase 2 Active not recruiting 14 enrolled Jordan Kharofa
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.

Timeline

Start
2017-01-04
Primary completion
2022-04-07
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Background Mitomycin C Other / unclassified 10 mg/m2
Background fluorouracil Small molecule 1000 mg/m2

Indications